SCHEMBL23023264

SCHEMBL23023264

O=C(CNC(=O)c1cccc(CN2CCN(c3ccccn3)CC2)c1)c1c#cccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.48
▸ DRD4 P21917 2/20 0.48
▸ HTT P42858 4/20 0.46
▸ LMNA P02545 3/20 0.46
▸ TSHR P16473 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ SLC6A4 P31645 1/20 0.45
▸ HTR7 P34969 1/20 0.44
▸ HTR1A P08908 1/20 0.44
▸ DRD2 P14416 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23014151 0.86 ALDH1A1 (0.56) ALDH1A1DRD4HTTLMNATSHR
SCHEMBL23014123 0.80 DRD4 (0.70) ALDH1A1DRD4HTTLMNATSHR
SCHEMBL23014286 0.77 HTR1A (0.55) ALDH1A1DRD4HTTTSHRKDM4E
SCHEMBL23014235 0.77 HTR1A (0.58) DRD4HTTLMNASMN1; SMN2SLC6A4
SCHEMBL23014362 0.70 HTR1A (0.57) ALDH1A1DRD4LMNATSHRKDM4E
SCHEMBL23014160 0.69 CHRM3 (0.61) ALDH1A1LMNATSHRSMN1; SMN2MAPK1
SCHEMBL4002378 0.69 DRD4 (0.69) ALDH1A1DRD4SLC6A4HTR1ADRD2
SCHEMBL4011544 0.69 DRD4 (0.67) ALDH1A1DRD4LMNAKDM4EHPGD
SCHEMBL23014309 0.68 CACNA1G (0.52) ALDH1A1TSHRKDM4ESMN1; SMN2HPGD
SCHEMBL4004278 0.68 ALDH1A1 (0.69) ALDH1A1DRD4SMN1; SMN2SLC6A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021034087-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND 주식회사 셀젠텍 2021-02-25 — — WO disclosed
Send feedback